subscribeSubscribe
US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug

US FDA withdraws approval for Covis Pharma`s preterm birth prevention drug
REUTERS
07 Apr 2023
Share Share
Controversial drug for preterm birth to be withdrawn, maker says

Controversial drug for preterm birth to be withdrawn, maker says
BIOPHARMADIVE
09 Mar 2023
Share Share
Covis granted FDA hearing over premature-birth med Makena

Covis granted FDA hearing over premature-birth med Makena
N. H. Dunn FIERCEPHARMA
21 Aug 2021
Share Share
FDA, unmoved by new meta-analysis, still recommends Makena withdrawal

FDA, unmoved by new meta-analysis, still recommends Makena withdrawal
Kari Oakes RAPS
30 Mar 2021
Share Share
AMAG Pharmaceuticals Requests Hearing to Maintain Makena®

AMAG Pharmaceuticals Requests Hearing to Maintain Makena®
GLOBENEWSWIRE
14 Oct 2020
Share Share
FDA seeks withdrawal of Makena, generics from market

FDA seeks withdrawal of Makena, generics from market
M. Mezher RAPS
06 Oct 2020
Share Share
FDA Proposes Withdrawing Makena`s Approval

FDA Proposes Withdrawing Makena`s Approval
MEDSCAPE
05 Oct 2020
Share Share
FDA seeks withdrawal of Makena, generics from market

FDA seeks withdrawal of Makena, generics from market
RAPS
05 Oct 2020
Share Share
Covis Group to acquire AMAG Pharmaceuticals in $647m deal

Covis Group to acquire AMAG Pharmaceuticals in $647m deal
PHARMAFILE
05 Oct 2020
Share Share
Covis Group to acquire AMAG Pharmaceuticals in $647m deal

Covis Group to acquire AMAG Pharmaceuticals in $647m deal
PHARMAFILE
05 Oct 2020
Share Share